Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JUNE 25, 2021

Professor David Nutt commented, “I am delighted to take on the role of Chief Research Officer in this exciting new biotechnology company that promises to revolutionise the treatment of addictions. Awakn’s combination of pre-clinical and clinical research uniquely positions Awakn to solve some of the biggest societal problems.”.

Research and Development 51

Research and Development Therapy Medicine Pets 51

Cannabis Law Report

JUNE 21, 2019

The Act is designed to help address several social issues that include “allowing law enforcement to focus on violent and property crimes, generating revenue for education, substance abuse prevention and treatment, freeing public resources … and individual freedom.” This article appeared in Cannabis Business Executive on June 11, 2019.

Concentrates 40

Concentrates Policy Programs Dispensary 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 11, 2019

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. Compensation is not payable for treatments that “simply improve the plaintiff’s enjoyment of life” 32.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

JULY 9, 2019

A medicinal product by function has a significant influence on the human physiological functions by a pharmacological effect in connection with the prevention or treatment of a disease or has a medical-therapeutical benefit 5 . food/safety/novel_food/catalogue/search/public/index.cfm#. In respect of the use of Cannabis sativa L.

Food 40

Food Seed-To-Sale Sativa Extraction 40

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

Canna Law Blog

OCTOBER 1, 2020

According to the CSA (and subsequent regulations ), Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. The Schedule I listing was significant. For reference, Schedule I includes heroin.

History 98

History Law DEA Safety 98

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 88

Marijuana Therapy Data THC 88

The Cannigma

JANUARY 13, 2023

3 A 2009 study touched on the trigeminal system as well, examining the connection between the CB1 gene (called CNR1) and people who reported migraines. Daily cannabis consumption was an effective treatment for 85% of participants. 5 THC and migraines THC is well-known for its anti-nausea and pain-relieving effects. headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

DECEMBER 12, 2022

Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. It became illegal in the US in 2009.

History 119

History Microdosing Research and Development Clinical Trials 119

SpeedWeed

JULY 19, 2021

The document in question was a 2020 safety study of the vape cartridge additive phytol. Certain vape additives are associated with lung injury, which shows up as cloudy on the left x-ray, and clear after treatment of one suspected VAPI patient in Utah. An alarming study of the vape additive phytol has rocked the cannabis vaping world.

Vaping 52

Vaping Terpenes Data Research and Development 52

Cannabis Law Report

OCTOBER 20, 2019

She was the Presiding Judge 2009 and 2010 and the co-founder of the Denver County Court Sobriety Court. It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.” Author Biography.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

JANUARY 10, 2020

Starting in 2009, the DOJ began to issue guidance to defer marijuana regulation and enforcement to states that had legalized medical marijuana, which helped establish confidence in the sustainability of the industry. xxxvii Colorado Division of Criminal Justice, Department of Public Safety. Department of Justice (DOJ).

Banking 45

Banking Marijuana Collective Recreational 45

Cannabis Law Report

JANUARY 21, 2019

The Act changes California’s conformity date to the Internal Revenue Code from January 1, 2009, to January 1, 2015. The California treatment of pension income is generally the same as federal treatment. BCC has provided guidance with respect to the retention of required accounting records in Sec.

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009. She is interested in the theme of ‘connectedness to Self, others, and the world’ as an important aspect of psychedelic treatment.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51